(PharmaNewsWire.Com, March 18, 2020 ) The report "Cell Counting Market by Product (Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), Consumables (Reagent, Assay Kits, Microplate)), End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2023", The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%.
By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018 On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures. The growing focus on stem cell and cancer research is one of the major drivers for the growth of the cell counting consumables market along with the growing application of cell counting in quality control procedures in various industries, such as food and beverage, pharmaceutical, biotechnology products manufacturing, environmental monitoring, and water treatment. By application, the research applications segment is estimated to hold the largest share in 2018 Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market. The large share of this segment can be attributed to the growing adoption of various cell counting instruments in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, HIV, drug discovery, and stem cells. Download an Illustrative overview of the report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62445948 Key Players Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), BioTek Instruments (US), GE Healthcare (US), PerkinElmer (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), and Sysmex Corporation (Japan) Danaher Corporation was the leading player in the cell counting market and accounted for the largest share in 2017. The company has a diversified product portfolio, which comprises of a wide range of instruments and consumables. Danaher offers a number of cell counters, flow cytometers, and hematology analyzers along with a wide range of consumables. Within the Danaher Business System (DBS) framework, the company is pursuing the expansion of its portfolio into new and attractive business areas. It significantly invests in R&D activities to add innovative technologies and products to its portfolio, which, in turn, helps it to strengthen its presence in the market. In 2018, the company launched the DxH 900 hematology analyzer, and in 2017, the company launched two new flow cytometry systems. Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=62445948
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
